BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 30652992)

  • 1. Re: Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import.
    Atala A
    J Urol; 2019 Apr; 201(4):668. PubMed ID: 30652992
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import.
    Rodriguez-Bravo V; Pippa R; Song WM; Carceles-Cordon M; Dominguez-Andres A; Fujiwara N; Woo J; Koh AP; Ertel A; Lokareddy RK; Cuesta-Dominguez A; Kim RS; Rodriguez-Fernandez I; Li P; Gordon R; Hirschfield H; Prats JM; Reddy EP; Fatatis A; Petrylak DP; Gomella L; Kelly WK; Lowe SW; Knudsen KE; Galsky MD; Cingolani G; Lujambio A; Hoshida Y; Domingo-Domenech J
    Cell; 2018 Aug; 174(5):1200-1215.e20. PubMed ID: 30100187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Nucleoporin POM121-Importin β Axis in Prostate Cancer.
    Lim KS; Wong RW
    Cell Chem Biol; 2018 Sep; 25(9):1056-1058. PubMed ID: 30241601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel nucleoporin drives aggressiveness.
    Bradley CA
    Nat Rev Urol; 2018 Nov; 15(11):658. PubMed ID: 30154428
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
    Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
    Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E2F1/DNMT1 axis is associated with the development of AR negative castration resistant prostate cancer.
    Valdez CD; Kunju L; Daignault S; Wojno KJ; Day ML
    Prostate; 2013 Dec; 73(16):1776-85. PubMed ID: 24038143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoporin 62 and Ca(2+)/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells.
    Karacosta LG; Kuroski LA; Hofmann WA; Azabdaftari G; Mastri M; Gocher AM; Dai S; Hoste AJ; Edelman AM
    Prostate; 2016 Feb; 76(3):294-306. PubMed ID: 26552607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLS-mediated NPC functions of the nucleoporin Pom121.
    Yavuz S; Santarella-Mellwig R; Koch B; Jaedicke A; Mattaj IW; Antonin W
    FEBS Lett; 2010 Aug; 584(15):3292-8. PubMed ID: 20624389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear transportation of exogenous epidermal growth factor receptor and androgen receptor via extracellular vesicles.
    Read J; Ingram A; Al Saleh HA; Platko K; Gabriel K; Kapoor A; Pinthus J; Majeed F; Qureshi T; Al-Nedawi K
    Eur J Cancer; 2017 Jan; 70():62-74. PubMed ID: 27886573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells.
    Saporita AJ; Ai J; Wang Z
    Prostate; 2007 Apr; 67(5):509-20. PubMed ID: 17221841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen regulates Cdc6 transcription through interactions between androgen receptor and E2F transcription factor in prostate cancer cells.
    Mallik I; Davila M; Tapia T; Schanen B; Chakrabarti R
    Biochim Biophys Acta; 2008 Oct; 1783(10):1737-44. PubMed ID: 18541154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer.
    Kang HY; Huang HY; Hsieh CY; Li CF; Shyr CR; Tsai MY; Chang C; Chuang YC; Huang KE
    J Bone Miner Res; 2009 Jul; 24(7):1180-93. PubMed ID: 19257827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes.
    Funakoshi T; Maeshima K; Yahata K; Sugano S; Imamoto F; Imamoto N
    FEBS Lett; 2007 Oct; 581(25):4910-6. PubMed ID: 17900573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation of inner nuclear membrane targeting sequences in mammalian Pom121 and yeast Heh2 membrane proteins.
    Kralt A; Jagalur NB; van den Boom V; Lokareddy RK; Steen A; Cingolani G; Fornerod M; Veenhoff LM
    Mol Biol Cell; 2015 Sep; 26(18):3301-12. PubMed ID: 26179916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BGLF4 kinase modulates the structure and transport preference of the nuclear pore complex to facilitate nuclear import of Epstein-Barr virus lytic proteins.
    Chang CW; Lee CP; Su MT; Tsai CH; Chen MR
    J Virol; 2015 Feb; 89(3):1703-18. PubMed ID: 25410863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
    McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
    Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.
    Tan SH; Dagvadorj A; Shen F; Gu L; Liao Z; Abdulghani J; Zhang Y; Gelmann EP; Zellweger T; Culig Z; Visakorpi T; Bubendorf L; Kirken RA; Karras J; Nevalainen MT
    Cancer Res; 2008 Jan; 68(1):236-48. PubMed ID: 18172316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer.
    Ashikari D; Takayama K; Tanaka T; Suzuki Y; Obinata D; Fujimura T; Urano T; Takahashi S; Inoue S
    Oncogene; 2017 Nov; 36(45):6272-6281. PubMed ID: 28692047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA.
    Grad JM; Dai JL; Wu S; Burnstein KL
    Mol Endocrinol; 1999 Nov; 13(11):1896-911. PubMed ID: 10551783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus.
    Shiota M; Yokomizo A; Masubuchi D; Tada Y; Inokuchi J; Eto M; Uchiumi T; Fujimoto N; Naito S
    Prostate; 2010 Apr; 70(5):540-54. PubMed ID: 19938016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.